SciTech Specialities Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SciTech Specialities Pvt. Ltd. - overview
Established
2007
Location
Mumbai, Maharashtra, India
Primary Industry
Pharmaceuticals
About
Based in India, SciTech Specialities focuses on manufacturing and distributing effervescent healthcare products, utilizing innovative aqueous technology to enhance health through easily consumable solutions. Founded in 2007 and headquartered in Mumbai, India, SciTech Specialities Pvt. Ltd. specializes in effervescent healthcare products.
The company has undergone significant growth since its inception and has successfully raised a total of INR 16. 25 mn across multiple funding rounds. The latest funding round, an Add-on round, occurred on December 28, 2020, led by Advanced Enzyme Technologies Limited, which acquired a majority stake in the company for approximately INR 316. 2 mn.
The founder, Predeep Gadre, has previously been involved in other entrepreneurial ventures, contributing to the company's strategic vision. SciTech Specialities manufactures and markets a variety of effervescent healthcare products through its aqueous technology. Its core offerings include effervescent tablets and SoluGran, which cater to diverse needs in pharmaceutical, nutraceutical, herbal, cosmeceutical, poultry, and pet care sectors. These products are marketed globally, targeting healthcare providers, retailers, and distributors seeking quality solutions for both human and animal health.
In the most recent fiscal year of 2024, SciTech Specialities reported a revenue of INR 5,141,389. 7, with an EBITDA of INR 1,140,839. 8. The company's structured business model supports revenue generation through direct sales and partnerships with retailers and wholesalers, enabling accessibility while maintaining product quality.
Moving forward, SciTech Specialities plans to leverage the recent acquisition by Advanced Enzyme Technologies Limited to expand its offerings in human health, animal nutrition, and food sectors. The company aims to introduce new product lines and enhance its delivery systems for existing offerings. The proceeds from the recent funding will also be directed towards expanding production capacity, investing in quality control, and reinvesting in company growth initiatives.
Current Investors
Advanced Enzyme Technologies Limited
Primary Industry
Pharmaceuticals
Sub Industries
Health Foods & Nutritional Supplements, Pharmaceutical Research & Development, Specialty Pharmaceuticals, Medicinal Chemicals & Botanicals
Website
www.scitech.net.in
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
SciTech Specialities Pvt. Ltd. - timeline of key events
SciTech Specialities Pvt. Ltd. - financials
| Fiscal Year Ended | Mar 31, 2011 | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 51,792,455.6 | 46,836,407 | - | - | 79,361,188 | 107,312,311 | 147,746,928.1 | 184,646,405.6 | 215,582,685.2 | 266,824,018.8 | 378,100,000 | - | - | - |
| % Revenue Growth (YoY) | - | (9.6%) | - | - | - | 35.2% | 37.7% | 25.0% | 16.8% | 23.8% | 41.7% | - | - | - |
| EBITDA (USD) | 21,678,914.6 | 17,528,408.3 | - | - | 34,895,478.1 | 25,584,287.4 | 39,655,768.1 | 47,598,642.6 | 57,497,524.7 | 58,563,453.3 | 98,510,000 | - | - | - |
| Operating Income (USD) | 18,754,526.6 | 13,098,448.3 | - | - | 20,152,670.1 | 10,180,920.4 | 24,250,753.1 | 28,890,907.6 | 27,127,151.9 | 30,328,597.3 | 67,580,000 | - | - | - |
| Operating Margin | 36.2% | 28.0% | - | - | 25.4% | 9.5% | 16.4% | 15.6% | 12.6% | 11.4% | 17.9% | - | - | - |
| % EBITDA Margin | 41.9% | 37.4% | - | - | 44.0% | 23.8% | 26.8% | 25.8% | 26.7% | 21.9% | 26.1% | - | - | - |
| NET Income (USD) | 11,120,690.7 | 7,155,999.9 | 5,860,742.6 | 5,300,603.4 | 6,976,400.4 | 969,481.1 | 6,649,790.3 | 10,825,487 | 7,600,209.4 | 10,068,806.3 | 38,800,000 | - | - | - |
| % Net Margin | 21.5% | 15.3% | - | - | 8.8% | 0.9% | 4.5% | 5.9% | 3.5% | 3.8% | 10.3% | - | - | - |
SciTech Specialities Pvt. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | SciTech Specialities Pvt. Ltd. | - |
Displaying 1 - 1 of 1
SciTech Specialities Pvt. Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.